Work

Use of Alternative Dosing Efgartigimod for the Treatment of Myasthenia Gravis (P1-11.020)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000212227

Authors: John Sturgis, Komal Sawlani, David Preston, Bashar Katirji

Institutions: University Hospitals of Cleveland, University Hospitals Cleveland Medical Center

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409227633

FWCI:

Cites:

Cited by:

Related to: 10